Vitolo, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.047
AS - Asia 6.937
EU - Europa 3.767
SA - Sud America 1.123
OC - Oceania 260
AF - Africa 146
Continente sconosciuto - Info sul continente non disponibili 4
Totale 20.284
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.853
SG - Singapore 2.218
CN - Cina 1.970
IT - Italia 1.165
HK - Hong Kong 987
BR - Brasile 902
VN - Vietnam 672
GB - Regno Unito 552
FI - Finlandia 449
SE - Svezia 364
DE - Germania 311
KR - Corea 310
AU - Australia 253
RU - Federazione Russa 246
FR - Francia 188
ID - Indonesia 129
IN - India 115
CA - Canada 90
AR - Argentina 86
NL - Olanda 67
BD - Bangladesh 66
MX - Messico 65
BG - Bulgaria 60
IQ - Iraq 58
TR - Turchia 55
JP - Giappone 54
AE - Emirati Arabi Uniti 50
PL - Polonia 45
ZA - Sudafrica 45
AT - Austria 43
PK - Pakistan 40
UA - Ucraina 40
ES - Italia 39
LT - Lituania 35
EC - Ecuador 32
CO - Colombia 31
UZ - Uzbekistan 30
IE - Irlanda 29
MA - Marocco 25
VE - Venezuela 22
MY - Malesia 21
KE - Kenya 20
EG - Egitto 18
SA - Arabia Saudita 18
AZ - Azerbaigian 16
CL - Cile 16
RS - Serbia 16
TH - Thailandia 16
CH - Svizzera 13
CZ - Repubblica Ceca 13
JO - Giordania 13
OM - Oman 12
PH - Filippine 12
RO - Romania 12
TN - Tunisia 12
TW - Taiwan 12
AL - Albania 11
BE - Belgio 10
BO - Bolivia 10
NP - Nepal 10
PY - Paraguay 10
DZ - Algeria 9
KZ - Kazakistan 9
PE - Perù 8
IL - Israele 7
NZ - Nuova Zelanda 7
HU - Ungheria 6
TT - Trinidad e Tobago 6
BA - Bosnia-Erzegovina 5
BY - Bielorussia 5
CU - Cuba 5
DO - Repubblica Dominicana 5
GE - Georgia 5
KG - Kirghizistan 5
LU - Lussemburgo 5
LV - Lettonia 5
NG - Nigeria 5
PT - Portogallo 5
UY - Uruguay 5
CY - Cipro 4
EE - Estonia 4
HR - Croazia 4
IR - Iran 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
BN - Brunei Darussalam 3
CR - Costa Rica 3
DK - Danimarca 3
ET - Etiopia 3
GT - Guatemala 3
LB - Libano 3
LK - Sri Lanka 3
MT - Malta 3
NO - Norvegia 3
SI - Slovenia 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
GD - Grenada 2
GR - Grecia 2
Totale 20.257
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.446
Singapore 1.396
Ashburn 983
Hong Kong 978
Hefei 891
San Jose 599
Chandler 427
Fairfield 395
Helsinki 390
London 317
Seoul 304
Nyköping 283
Beijing 276
The Dalles 255
Ho Chi Minh City 217
New York 204
Woodbridge 169
Houston 167
Perth 167
Seattle 158
Council Bluffs 151
Hanoi 150
Los Angeles 144
Wilmington 140
Cambridge 127
Chicago 125
Milan 107
San Diego 106
Bologna 105
Jakarta 103
Munich 97
São Paulo 92
Modena 86
Buffalo 84
Dallas 80
Lauterbourg 79
Shanghai 77
Rome 76
Princeton 69
Ann Arbor 67
Moscow 63
Southend 63
Sofia 56
Salt Lake City 52
Kent 50
Da Nang 42
Frankfurt am Main 41
Sydney 41
Tokyo 38
Lappeenranta 36
Johannesburg 34
Orem 34
Toronto 32
Nuremberg 30
Haiphong 28
Tashkent 28
Amsterdam 27
Dublin 27
Redondo Beach 27
Kilburn 26
Mexico City 26
Montreal 25
Rio de Janeiro 25
Warsaw 25
Columbus 24
Atlanta 23
Guangzhou 23
Parma 23
Chennai 22
Turku 22
Denver 21
Schiffdorf 21
Baghdad 20
Elk Grove Village 20
Naples 20
Reggio Emilia 20
Biên Hòa 19
Stockholm 19
Tampa 19
Turin 19
Vienna 19
Phoenix 18
Belo Horizonte 17
Campinas 17
Jacksonville 17
Miami 17
Paris 17
Portsmouth 17
Dubai 16
Düsseldorf 15
Nairobi 15
Ankara 14
Boardman 14
Boston 14
Brasília 14
Brooklyn 14
Eugene 14
Fortaleza 14
Hải Dương 14
Istanbul 14
Totale 13.609
Salva come PNG Salva come JPEG
Nome #
Atrial Fibrillation in the Setting of Acute Pneumonia: Not a Secondary Arrhythmia 488
Radar-Based Monitoring of Vital Signs: A Tutorial Overview 321
Cardiolaminopathies from bench to bedside: challenges in clinical decision-making with focus on arrhythmia-related outcomes 296
Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis 296
2022 ESC Guidelines for the management of ventricular arrhythmias and sudden cardiac death: an important focus on a multidisciplinary approach to a tailored diagnostic and therapeutic work-up|Linee guida europee 2022 su aritmie ventricolari e morte cardiaca improvvisa: un importante impulso a un impegno multidisciplinare in campo diagnostico e terapeutico per un’accurata personalizzazione dell’approccio clinico 249
The role of physical activity in individuals with cardiovascular risk factors: an opinion paper from Italian Society of Cardiology-Emilia Romagna-Marche and SIC-Sport 242
Cardioversion of recent-onset atrial fibrillation: current evidence, practical considerations, and controversies in a complex clinical scenario 239
Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients 236
DIGItal Health Literacy after COVID-19 Outbreak among Frail and Non-Frail Cardiology Patients: The DIGI-COVID Study 229
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry 227
Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis 222
Progression of Atrial Fibrillation after Cryoablation 214
Comparative analysis of level of evidence and class of recommendation for 50 clinical practice guidelines released by the European Society of Cardiology from 2011 to 2022 209
Percutaneous pericardiocentesis for pericardial effusion: predictors of mortality and outcomes 209
Atrial cardiomyopathy: An entity of emerging interest in the clinical setting 206
Atrial fibrillation burden: Stepping beyond the categorical characterization 201
Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillation 197
Red cell distribution width: a routinely available biomarker with important clinical implications in patients with atrial fibrillation 195
Atrial fibrillation and remote monitoring through cardiac implantable electronic devices in heart failure patients 194
What do we do about atrial high rate episodes? 188
Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials? 187
The 2024 ESC guidelines on atrial fibrillation: essential updates for everyday clinical practice 185
Female sex and stroke in atrial fibrillation: an intriguing relationship 185
The Euro Heart Survey and EURObservational Research Programme (EORP) in atrial fibrillation registries: contribution to epidemiology, clinical management and therapy of atrial fibrillation patients over the last 20 years 185
Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology 185
Atrial fibrillation in patients with cardiac implantable electronic devices: New perspectives with important clinical implications 184
Usefulness of Red Cells Distribution Width to Predict Worse Outcomes in Patients With Atrial Fibrillation 183
Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosis 181
Managing atrial fibrillation: the need for an individualized approach even in the emergency department 179
Short and long-term outcomes after cardiac surgery in Jehovah's Witnesses patients: a case-control study 177
Three-Dimensional Automated, Machine-Learning-Based Left Heart Chamber Metrics: Associations with Prevalent Vascular Risk Factors and Cardiovascular Diseases 176
Impact of body mass index on the outcome of elderly patients treated with transcatheter aortic valve implantation 176
Atrial high-rate episodes: clinical significance, prognostic impact and clinical management 175
Atrial Fibrillation and the Risk of Early‐Onset Dementia: A Systematic Review and Meta‐Analysis 174
Red blood cell distribution width in patients undergoing transcatheter aortic valve implantation: Implications for outcomes 174
Low Occurrence of Infections and Death in a Real-World Cohort of Patients with Cardiac Implantable Electronic Devices 173
Atrial fibrillation before and after transcatheter aortic valve implantation: short- and long-term clinical implications 172
Single-lead VDD pacing: a literature review on short-term and long-term performance 171
Anticoagulation to prevent ischemic stroke in patients with atrial fibrillation: a complex scenario including underdiagnosis, undertreatment or underdosing of oral anticoagulants 171
Adherence to the “Atrial fibrillation Better Care” (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry 170
Atrial Fibrillation and Other Cardiovascular Factors and the Risk of Dementia: An Italian Case–Control Study 168
Cardiac Surgery in Jehovah's Witnesses Patients and Association With Peri-Operative Outcomes: A Systematic Review and Meta-Analysis 168
Permanent Atrial Fibrillation as the Terminal Stage of a Chronic Disease: Palliative Care Needs to be Considered in Selected Patients with Markedly Impaired Quality of Life 167
Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes 167
Radiotherapy-induced malfunctions of cardiac implantable electronic devices in cancer patients 166
Atrial cardiomyopathy: a derangement in atrial volumes, geometry, function, and pathology with important clinical implications 166
Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device 163
Cognitive impairment in patients with atrial fibrillation: Implications for outcome in a cohort study 161
Atrial fibrillation in pneumonia: what clinical implications at long-term? 160
Ibrutinib and Bruton's tyrosine kinase inhibitors in chronic lymphocytic leukemia: focus on atrial fibrillation and ventricular tachyarrhythmias/sudden cardiac death 159
A systematic review and meta-analysis on oncological radiotherapy in patients with a cardiac implantable electronic device: Prevalence and predictors of device malfunction in 3121 patients 159
Cardiovascular Reasons for Access to a Tertiary Oncological Emergency Service: The CARILLON Study 156
Atrial fibrillation screening: Great debate on which approach to apply, which tools to use and which population to target 153
Grey zones in the practice of permanent cardiac pacing: The case of preventive pacing for improving rhythm control in atrial fibrillation 153
Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: A state-of-the-art review 152
Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients 152
Anthropometric parameters and radiation doses during percutaneous coronary procedures 151
Features of Clinical Complexity in European Patients With Atrial Fibrillation: A Report From a European Observational Prospective AF Registry 150
Atrial fibrillation in vascular surgery: a systematic review and meta-analysis on prevalence, incidence and outcome implications 150
Ventricular and Atrial Remodeling after Transcatheter Edge-to-Edge Repair: A Pilot Study 149
Biomarkers in atrial fibrillation: A constant search for simplicity, practicality, and cost-effectiveness 149
Clinical phenotype classification of atrial fibrillation patients using cluster analysis and associations with trial-adjudicated outcomes 149
Association of comorbidity patterns with outcomes and relation with the ABC pathway effectiveness in European patients with atrial fibrillation 148
COVID-19 pandemic: complex interactions with the arrhythmic profile and the clinical course of patients with cardiovascular disease 147
Quantification of Myocardial Contraction Fraction with Three-Dimensional Automated, Machine-Learning-Based Left-Heart-Chamber Metrics: Diagnostic Utility in Hypertrophic Phenotypes and Normal Ejection Fraction 146
Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations 146
Remote multiparametric monitoring and management of heart failure patients through cardiac implantable electronic devices 145
From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach 145
Systematic review and meta-Analysis on the impact on outcomes of device algorithms for minimizing right ventricular pacing 141
Clinical decisions for appropriate management of patients with atrial fibrillation 141
Cardiac resynchronization therapy: Need to synchronize patients and device longevities with comorbidities 141
Cardiac resynchronization therapy: variations across Europe in implant rates and types of implanted devices 140
Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry 137
Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients 136
Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry 136
Implantable cardioverter defibrillators and devices for cardiac resynchronization therapy: what perspective for patients’ apps combined with remote monitoring? 135
Burden of disease and costs of infections associated with cardiac implantable electronic devices 134
Comparing outcomes in asymptomatic and symptomatic atrial fibrillation: A systematic review and meta-analysis of 81,462 patients 133
Atrial fibrillation and HIV: a new association requiring pathophysiological and outcome studies 132
Driving restriction in patients with cardiac implantable electronic devices: an overview of worldwide regulations 130
Atrial high rate episodes as a marker of atrial cardiomyopathy: In the quest of the Holy Grail. Author's reply 130
Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry 129
Rhythm- or rate-control strategies according to 4S-AF characterization scheme and long-term outcomes in atrial fibrillation patients: the FAMo (Fibrillazione Atriale in Modena) cohort 127
GESTIONE CLINICA, COMORBIDITÀ ED EVENTI AVVERSI ASSOCIATI IN PAZIENTI CON FIBRILLAZIONE ATRIALE: ANALISI DA UNO STUDIO DI COORTE EUROPEO SU OLTRE 11.000 PAZIENTI 126
Tailored oral anticoagulant prescription in patients with atrial fibrillation: Use and misuse of clinical risk prediction scores 125
Cardiomyopathy associated with long-term right ventricular pacing: an intriguing clinical issue 124
Yield of diagnosis and risk of stroke with screening strategies for atrial fibrillation: a comprehensive review of current evidence 123
The importance of adherence and persistence with oral anticoagulation treatment in patients with atrial fibrillation 123
Comparison of HAS-BLED and ORBIT Bleeding Risk Scores in AF Patients treated with NOACs: A Report from the ESC-EHRA EORP-AF General Long-Term Registry 123
Digital literacy as a potential barrier to implementation of cardiology tele-visits after COVID-19 pandemic: The INFO-COVID survey 123
Epidemiology and impact of frailty in patients with atrial fibrillation in Europe 122
The 12-lead ECG: A continuous reference for the cardiologist 122
Red cell distribution width and patient outcome in cardiovascular disease: A ‘’real-world” analysis 122
Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the European Society of Cardiology (ESC)-European Heart Rhythm Association (EHRA) EurObservational Research Programme on Atrial Fibrillation (EORP-AF) general long-term registry 122
Kidney Function According to Different Equations in Patients Admitted to a Cardiology Unit and Impact on Outcome 120
Chronic Kidney Disease with Mild and Mild to Moderate Reduction in Renal Function and Long-Term Recurrences of Atrial Fibrillation after Pulmonary Vein Cryoballoon Ablation 120
Atrial fibrillation post-coronary or cardiac surgery: A transient inflammation-related event or the expression of a pre-existing arrhythmogenic atrial substrate? 119
Clinical Profile, Arrhythmias, and Adverse Cardiac Outcomes in Emery–Dreifuss Muscular Dystrophies: A Systematic Review of the Literature 118
CHA2DS2-VA instead of CHA2DS2-VASc for stroke risk stratification in patients with atrial fibrillation: not just a matter of sex 117
How did COVID-19 affect medical and cardiology journals? A pandemic in literature 115
Totale 16.852
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.454
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.454
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021138 0 0 0 0 0 0 0 0 0 0 67 71
2021/20221.164 72 80 20 38 39 102 30 57 128 99 244 255
2022/20231.454 155 154 119 69 125 175 49 149 206 44 130 79
2023/20241.648 52 86 107 170 283 238 123 213 38 51 87 200
2024/20255.807 131 91 299 364 991 780 546 346 564 414 618 663
2025/20269.258 744 437 901 1.119 1.060 600 1.624 573 1.180 938 82 0
Totale 20.477